Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access Highly Access Email this article to a friend

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

Dirk Koczan, Susanne Drynda, Michael Hecker, Andreas Drynda, Reinhard Guthke, Joern Kekow and Hans-Juergen Thiesen*

Arthritis Research & Therapy 2008, 10:R50 doi:10.1186/ar2419

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.